Recent Quotes (30 days)

You have no recent quotes
chg | %

Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 187   

Articles published

BMY 64.67 +0.97 (1.52%)
price chart
Jefferies Downgrades Bristol-Myers Squibb Co. (BMY) to Hold
Jefferies downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Hold with a price target of $71.00 (from $72.00). Analyst Jeff Holford sees limited upside from the current valuation.
Bristol-Myers Stock May Have Exhausted Its Upside For Now  Benzinga
Target Pharmasolutions, Bristol-Myers Squibb Co (NYSE:BMY) Extend Partnership  Market Exclusive
Sabal Trust CO Buys United Parcel Service Inc, Bristol-Myers Squibb Company ...
Sabal Trust CO initiated holdings in United Parcel Service Inc. The purchase prices were between $107.79 and $120.09, with an estimated average price of $113.65.
Bristol-Myers Squibb (BMY): Raising PT To $72 - Citi  StreetInsider.com
As Bristol Myers Squibb Co (BMY) Shares Declined, Arizona State Retirement ...  BZ Weekly
Strategy To YieldBoost Bristol-Myers Squibb Co. From 2.5% To 7.2% Using Options
Shareholders of Bristol-Myers Squibb Co. (Symbol: BMY) looking to boost their income beyond the stock's 2.5% annualized dividend yield can sell the June 2018 covered call at the $70 strike and collect the premium based on the $2.10 bid, which ...
Must-Know Changes to Bristol-Myers Squibb's Valuation  Market Realist
Analysts See $0.75 EPS for Bristol-Myers Squibb Co (BMY)  WeeklyHub
Bristol-Myers Squibb Co. (BMY) PT Raised to $72 at UBS; 'Shares Reflect Modest ...
UBS raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $72.00 (from $62.00) while maintaining a Buy rating, following a review of the company's outlook and update to the model.
How Important Is Eliquis For Bristol-Myers Squibb?  Forbes
Holder Bridgewater Associates LP Has Upped Bristol Myers Squibb Co (BMY ...  BZ Weekly
Lightning Round: Jim Cramer Weighs In On Bristol-Myers Squibb, Mazor Robotics ...
Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Bristol-Myers Squibb Co (NYSE: BMY). He said the stock came back and made a new high despite losing a bunch head-to-heads against Keytruda.
Ex-Dividend Reminder: Bristol-Myers Squibb, Kite Realty Group Trust and DCT ...
Looking at the universe of stocks we cover at Dividend Channel , on 10/5/17, Bristol-Myers Squibb Co. (Symbol: BMY), Kite Realty Group Trust (Symbol: KRG), and DCT Industrial Trust Inc (Symbol: DCT) will all trade ex-dividend for their respective ...
Bristol Myers Squibb Co (BMY) Market Valuation Declined While Arizona State ...  BZ Weekly
Bristol-Myers Squibb Co (BMY) Stock Raised to Hold
Portfolio Grader currently ranks Bristol-Myers Squibb Co (NYSE:BMY) a Hold. With exclusive fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly.
Sabal Trust CO Buys United Parcel Service Inc, Bristol-Myers Squibb Company ...
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.
Aureus Asset Management Lifted By $677820 Its Bristol Myers Squibb Co Com (BMY ...
Among 3 analysts covering Manx Telecom (LON:MANX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Manx Telecom had 23 analyst reports since August 5, 2015 according to SRatingsIntel.
Roche Enters a Competitive Storm With Shaky Defenses
Tecentriq is currently approved to treat bladder cancer -- where it must now compete with four similar medicines in the U.S. -- and in previously treated lung cancer, where it is playing catch-up with Bristol-Myers Squibb Co. and Merck & Co. Inc. Price ...